Federal health agencies asked states to pause in their use of the Johnson & Johnson vaccine while U.S. officials investigate reports of an extremely rare blood-clotting syndrome that has developed in six people who have received the vaccine. Given how few people are sick, why did the U.S. recommend a pause? And what's it say about how the monitoring system is working?
The podcast PODCAST-19: FiveThirtyEight on the Novel Coronavirus is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.